News Press Releases Theragenics and Clarity Pharmaceuticals Partner to Enable Scalable Copper-64 Supply for Next-Generation Diagnostics tgx-admin March 25, 2026
News Randomized Trial Supports Dose-De-Escalated Pd-103 LDR Brachytherapy for Low-Risk Prostate Cancer tgx-admin January 7, 2026
News New Study Highlights Underuse of Brachytherapy Boost in Prostate Cancer Treatment tgx-admin December 11, 2025
News Mapping the Future of Prostate Cancer Treatment: A Vision Led by Michael Krachon tgx-admin December 5, 2025
News Theragenics Launches New Patient Resources to Enhance Education and Support tgx-admin May 20, 2025
